ArticleBiomolecules & biomedicine2023

Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study.

Sabin Goktas Aydin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.